Assessing the economic impact of psychiatric disorders: where to begin?

Expert Opinion on Pharmacotherapy
P E GreenbergH G Birnbaum

Abstract

Over the past decade, psychiatric disorders have increasingly been regarded as serious public health concerns, with debilitating symptoms as well as high social and economic costs to patients, caregivers, third party payers and society. In this article, we review findings from recent research on psychiatric disorders, while providing a framework for assessing their pharmacoeconomic impact. In particular, we consider the prevalence of psychiatric disorders, their far-reaching impacts, and their associated treatment patterns. These categories present a starting point for analysing the pharmacoeconomic consequences of psychiatric disorders and underlie an expert opinion in this context

References

Oct 1, 1992·Archives of General Psychiatry·J MintzS S Hwang
Oct 1, 1992·Archives of General Psychiatry·G L Klerman, M M Weissman
Mar 18, 1992·JAMA : the Journal of the American Medical Association·J JohnsonG L Klerman
Feb 1, 1992·Archives of General Psychiatry·M Von KorffE H Lin
Nov 1, 1991·The American Journal of Psychiatry·G E Simon, M VonKorff
Nov 21, 1990·JAMA : the Journal of the American Medical Association·W E BroadheadC K Tse
Nov 1, 1990·General Hospital Psychiatry·W KatonE Polk
Aug 18, 1989·JAMA : the Journal of the American Medical Association·K B WellsJ Ware
Nov 1, 1986·General Hospital Psychiatry·A StoudemireD Blazer
Jun 22, 1985·British Medical Journal·P FreelingR H Burton
Oct 1, 1984·Archives of General Psychiatry·S ShapiroD A Regier
Oct 1, 1995·Archives of General Psychiatry·G E SimonW Barlow
Jul 1, 1995·The American Journal of Psychiatry·R C KesslerP E Stang
Jul 23, 1994·BMJ : British Medical Journal·N FreemantleT A Sheldon
Mar 1, 1995·The American Journal of Psychiatry·G SimonW Barlow
Jan 4, 1995·JAMA : the Journal of the American Medical Association·R Sturm, K B Wells
Apr 1, 1994·Archives of Family Medicine·K RostB Guise
Jun 26, 1996·JAMA : the Journal of the American Medical Association·G E SimonE H Wagner
Apr 1, 1996·The British Journal of Psychiatry : the Journal of Mental Science·M HotopfC Normand
Jan 22, 1997·JAMA : the Journal of the American Medical Association·R M HirschfeldR J Wyatt
Jan 1, 1997·Psychiatric Services : a Journal of the American Psychiatric Association·D J KatzelnickH J Henk
Jan 1, 1997·International Clinical Psychopharmacology·J P LépineA Tylee
May 1, 1997·International Clinical Psychopharmacology·W Rein, S Turjanski
Jul 1, 1997·Psychological Medicine·R C Kessler, R G Frank
Oct 27, 1997·The American Journal of Psychiatry·R C KesslerE E Walters
Aug 12, 1998·The American Journal of Psychiatry·R C KesslerM S Forthofer
Jan 19, 1999·The American Journal of Psychiatry·R C KesslerP Leaf
Jun 7, 1995·PharmacoEconomics·M I Wilde, R Whittington
Jan 8, 1996·PharmacoEconomics·M O HowardR D Walker
Dec 8, 1997·PharmacoEconomics·G E Simon, P Fishman
Apr 7, 1998·PharmacoEconomics·M I Wilde, P Benfield
Sep 4, 1996·PharmacoEconomics·R Davis, M I Wilde
Jul 21, 1999·Journal of Occupational and Environmental Medicine·A J ClaxtonS Kennedy
Oct 26, 1999·Journal of Occupational and Environmental Medicine·W N BurtonD W Edington
May 10, 2000·Psychiatry and Clinical Neurosciences·S TakahashiT Kojima
Jun 1, 2000·The American Journal of Psychiatry·E R BerndtM B Keller
Jun 10, 2000·The Journal of Clinical Psychiatry·V HendrickC Hammen

❮ Previous
Next ❯

Citations

Oct 1, 2001·Expert Review of Pharmacoeconomics & Outcomes Research·P E Greenberg, S A Birnbaum
Apr 1, 2009·Social Psychiatry and Psychiatric Epidemiology·Craig SteelAnna Ruddle

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.